WGS
GeneDx Holdings Corp.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$85.99
−1.60%Aug 11, 2026, 23:46 UTC
GeneDx Holdings Corp (WGS) shares rose 5.1% to $81.83 on August 11, 2026, in a volatile market.
Source:Aug 11, 2026, 12:30 UTC
GeneDx launched a new online offering to improve accessibility of exome testing for children with global developmental delay, intellectual disability, and epilepsy.
Source:Aug 8, 2026, 01:12 UTC
GeneDx Holdings Corp. announced a private placement of 81,967 Class A shares at US$61.00 each, with participation from a Blackstone affiliate.
Source:Aug 3, 2026, 20:05 UTC
GeneDx reported its financial and operational results for the second quarter of 2026.
Jul 31, 2026, 23:43 UTC
GeneDx Holdings Corp shares fell 5.5% to $65.12 on July 31, 2026.
Source:Jun 29, 2026, 08:39 UTC
A class action lawsuit was filed against GeneDx Holdings Corp. for alleged securities law violations.
Jun 16, 2026, 22:45 UTC
A class action lawsuit was filed against GeneDx Holdings Corp. alleging it misled investors regarding the impact of its acquisition of Fabric Genomics.
Jun 16, 2026, 00:00 UTC
GeneDx Holdings Corp. appointed Mark Gardner as President, effective June 15, 2026.
Source:Jun 15, 2026, 13:30 UTC
Barrack, Rodos & Bacine filed a class action lawsuit against GeneDx Holdings Corp. on behalf of purchasers of its common stock between April 16, 2025 and May 4, 2026.
Source:Jun 6, 2026, 00:00 UTC
A securities class action lawsuit has been filed against GeneDx Holdings Corp. in the United States District Court for the District of Connecticut on behalf of purchasers of its securities between April 16, 2025 and May 4, 2026.
Jun 4, 2026, 19:30 UTC
Hagens Berman opened an investigation into GeneDx Holdings Corp. for possible securities law violations after a 49% stock drop following a Q1 2026 earnings miss.
Source: